Files

665848.pdf (1.17 MB)

Document type

Article

Version

Published version

Publication date

2012-01-12

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/107066

Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1111/j.1474-9726.2011.00754.x

Abstract

Embryonic stem (ES) cells and induced pluripotent stem (iPS) cells represent a promising therapeutic tool for many diseases, including aged tissues and organs at high risk of failure. However, the intrinsic self-renewal and pluripotency of ES and iPS cells make them tumorigenic, and hence, the risk of tumor development hinders their clinical application. Here, we present a novel approach to limit their tumorigenicity and increase their safety through increased copy number of tumor suppressors. iPS containing an extra copy of the p53 or Ink4a/ARF locus show normal pluripotency, as determined by in vitro and in vivo differentiation assays. Yet, while retaining full pluripotency, they also possess an improved engagement of the p53 pathway during teratocarcinoma formation, which leads to a reduced tumorigenic potential in various in vitro and in vivo assays. Furthermore, they show an improved response to anticancer drugs, which could aid in their elimination in case tumors arise with no adverse effects on cell function or aging. Our system provides a model for studying tumor suppressor pathways during reprogramming, differentiation, and cell therapy applications. This offers an improved understanding of the pathways involved in tumor growth from engrafted pluripotent stem cells, which could facilitate the use of ES and iPS cells in regenerative medicine.

Subject

Cèl·lules mare embrionàries, Proteïnes supressores de tumors, Càncer, Transformació cel·lular, Envelliment

Subject (English)

Embryonic stem cells, Tumor suppressor protein, Cancer, Cell transformation, Aging

Citation

Collections

Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut de Biomedicina (IBUB))

Citation

MENENDEZ, Sergio, et al. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency. Aging Cell. 2012. Vol. 11, num. 1, pags. 41-50. ISSN 1474-9718. [consulted: 9 of June of 2026]. Available at: https://hdl.handle.net/2445/107066

Export metadata

JSON - METS

Share record